Benzothiazole, 2-(trifluoromethyl)- (CAS 347-64-2), a liquid at ambient conditions with a molecular weight of 215.17 g·mol⁻¹, functions as a high-value synthetic intermediate where the strong electron-withdrawing trifluoromethyl group imparts enhanced metabolic stability and modified ring electronics relative to halogenated analogs. The product is supplied in commercial quantities as a neat liquid with a minimum purity of 98.0% (GC area percent, internal standard method per ASTM E260). Custom packaging under nitrogen down to 200-L drums with UN 4G/Y certification is standard. The following sections detail its specifications, process chemistry differences, and comparative performance data against 2-chloro-, 2-bromo-, and 2-unsubstituted benzothiazoles.
Physicochemical benchmarks for halogenated analogs
| Property | 2-CF₃ | 2-Cl | 2-Br | 2-H |
|---|---|---|---|---|
| Molar mass (g·mol⁻¹) | 215.17 | 169.63 | 214.08 | 135.19 |
| Boiling point @ 760 mmHg (°C) | 198–200 | 248–250 | 260–262 | 230–232 |
| Density @ 20 °C (g·cm⁻³) | 1.38 | 1.30 | 1.63 | 1.18 |
| Refractive index nD²⁰ | 1.501 | 1.634 | 1.675 | 1.642 |
| clogP (BioByte v4.3) | 3.2 | 2.0 | 2.3 | 1.8 |
In continuous manufacturing platforms, the cyclocondensation of 2-aminothiophenol with trifluoroacetyl chloride proceeds through a highly exothermic hemiaminal intermediate. A Corning G1 SiC reactor with a plate heat exchanger enabled a steady-state throughput of 1.8 kg·h⁻¹ at 150 °C and 5 bar back-pressure. Residence time distribution analysis (pulse tracer, NaCl) confirmed plug-flow behavior with a variance σ² = 0.02, limiting the accumulation of the thermally sensitive intermediate to <0.5% at any axial position. The product stream was directly quenched into 10 wt% NaHCO₃ at 10 °C, achieving 97.9% in-situ GC purity without distillation. This contrasts with the batch mode where a productivity cap of 0.3 kg·h⁻¹ was imposed by jacket cooling limitations (glass-lined 200-L reactor, limitation of U = 350 W·m⁻²·K⁻¹).
When the 2-CF₃ Group Dictates Regioselectivity in Electrophilic Substitution
Nitration with mixed acid (HNO₃/H₂SO₄) at 0–5 °C generates the 6-nitro-2-(trifluoromethyl)benzothiazole isomer with >18:1 regioselectivity, as confirmed by 19F NMR of the crude reaction mixture. Reaction calorimetry (Mettler-Toledo RC1e) recorded an adiabatic temperature rise of ΔTad = 38 K, necessitating a dosing-controlled semi-batch protocol. This selectivity is a direct consequence of the strong –I effect of the CF₃ group, which deactivates the 4- and 7-positions toward electrophilic attack far more effectively than chlorine in the 2-chloro analog (isomer ratio 12:1 under identical conditions). The 6-nitro derivative is isolated by drowning in ice water and recrystallized from heptane/ethyl acetate (4:1 v/v) to >99.5% purity, with nitrophenol byproducts <0.05% by HPLC (USP <621>). This regiospecificity provides a distinct advantage in constructing constrained pharmacophores where a single substitution pattern is required without preparative chromatography.
How does oxygen partial pressure affect shelf-life at ambient storage?
Accelerated stability testing at 40 °C/75% RH under nitrogen vs. air headspace (ASTM F1980 protocol) showed a purity decline from 99.2% to 98.5% over 12 weeks under air, attributable to slow photo-oxidation at the thiazole sulfur. Under nitrogen, no detectable change occurred. Light exposure (ICH Q1B option 2) confirmed formation of a sulfoxide impurity with M+16 by LC-MS. Elastomer compatibility tests (immersion 7 days at 40 °C) revealed volume swell of 23% in NBR, 12% in EPDM, and 1.8% in FFKM. Only perfluoroelastomer seals (Kalrez 4079 or equivalent) are therefore recommended for pump diaphragms and reactor manways. Storage in amber glass vessels under <100 ppm O₂ headspace with a nitrogen blanket is required to maintain specification during long-term holding; bulk tanks should be equipped with breather vent driers using molecular sieve 3A.
What Limits the Use of 2-(Trifluoromethyl)benzothiazole in Large-Scale Negishi Couplings?
Unlike 2-bromobenzothiazole, the C-2 position of the CF₃ analog bears no halogen leaving group and therefore cannot undergo oxidative addition with Pd(0). This eliminates its direct utility in standard Pd-catalyzed cross-coupling at that site. However, the strong electron-withdrawing CF₃ group activates the 5-position toward directed ortho-metalation with LDA (1.2 equiv, THF, –78 °C) to generate a lithiated species that reacts with electrophiles—for example, DMF yields 5-formyl-2-(trifluoromethyl)benzothiazole with 89% isolated yield after quenching and extraction. Alternatively, an iridium-catalyzed C–H borylation with [Ir(COD)OMe]₂, dtbpy, and B₂pin₂ in MTBE at 50 °C installs a pinacol boronate at the 5-position in 83% yield, enabling subsequent Suzuki-Miyaura coupling. These divergent strategies contrast sharply with the straightforward 2-arylation accessible from 2-chloro- or 2-bromobenzothiazole. In medicinal chemistry campaigns, this operational constraint often prompts selection of 2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzothiazole when C-2 elaboration is prioritized, reserving the 2-CF₃ scaffold for targets where oxidative metabolic stability at the heterocycle is the primary design driver.
Release specifications and batch analysis data
| Parameter | Limit | Method |
|---|---|---|
| Assay (GC/FID, area %) | ≥ 98.0% | ASTM E260, internal standard |
| Water content | ≤ 0.10% | ASTM E203 (Karl Fischer) |
| Chloride ion | ≤ 50 ppm | USP <761> ion chromatography |
| Heavy metals (as Pb) | ≤ 10 ppm | USP <233> ICP-OES |
| Residual solvents | Class 3 ≤ 0.5% total | USP <467> HS-GC/MS |
| Appearance | Clear, colorless to pale yellow liquid | Visual comparison against APHA ≤ 50 standard |
A Type II drug master file (DMF) in eCTD format is maintained for pharmaceutical-grade lots. Export classification under harmonized tariff code 2934.20.8000; REACH registration covering the 1–10 t/a band has been completed.
In agrochemical lead optimization programs, replacing the 2-Cl substituent in a series of benzothiazole carboxamide fungicides with 2-CF₃ increased the hydrolytic half-life at pH 7.4 (phosphate buffer, 37 °C) from 4.2 h to >48 h, while retaining in vitro activity against Zymoseptoria tritici (EC₅₀ 0.06 mg·L⁻¹ vs. 0.09 mg·L⁻¹). This shift was attributed to the resistance of the C–CF₃ bond toward nucleophilic attack at the 2-position, a degradation pathway confirmed by LC-HRMS identification of the corresponding 2-hydroxybenzothiazole for the chloro analog. No equivalent metabolite was observed for the CF₃ compound under identical forced degradation (1 N HCl, 80 °C, 48 h). Such differential stability is routinely exploited in discovery programs targeting soil-borne pathogens where environmental persistence windows of 14 days or longer are required for efficacy.
In vulcanization chemistry, 2-(trifluoromethyl)benzothiazole serves as a precursor to experimental sulfenamide accelerators. Comparative cure kinetics in a model NR/BR (70/30) tread compound at 150 °C using a moving-die rheometer (ASTM D5289) showed that the 2-CF₃ substituted sulfenamide (N-cyclohexyl-2-(trifluoromethyl)benzothiazole sulfenamide) increased scorch time (ts2) by 2.4 min and reduced the cure rate index (CRI = 100/(t₉₀−tₛ₂)) from 8.3 min⁻¹ to 5.1 min⁻¹ relative to TBBS. The electron-withdrawing CF₃ group retards the cleavage of the S–N bond, thereby offering a wider processing safety window for thick-section rubber articles prone to premature crosslinking during extrusion. These differences underscore the role of the 2-CF₃ group as a tunable electronic handle that distinguishes this compound from its halo- and alkyl-substituted analogs across high-performance applications.
